Helicobacter pylori and bleeding duodenal ulcer: Prevalence of the infection and role of non-steroidal anti-inflammatory drugs

Scandinavian Journal of Gastroenterology

Volumn 36, Issue 7, 2001, Pages 717-724

  Gisbert, J P ^a   Gonzalez, L ^a   De Pedro, A ^a   Valbuena, M ^a   Prieto, B ^a   Llorca, I ^a   Briz, R ^a   Khorrami, S ^a   Garcia Gravalos, R ^a   Pajares, J M ^a  

^a Playa de Mojacar   (Spain)

Author keywords

13C urea breath test; Bleeding; Duodenal ulcer; Haemorrhage; Helicobacter pylori; Non steroidal anti inflammatory drugs; Omeprazole; Peptic ulcer

Indexed keywords

CARBON 13; CITRAL PYLORI; CITRIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE;

ADULT; AGED; ARTICLE; BLEEDING; BREATH ANALYSIS; CONTROLLED STUDY; DRUG USE; DUODENUM ULCER; ENDOSCOPY; EVALUATION; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATHOGENESIS; PEPTIC ULCER; PRIORITY JOURNAL; QUESTIONNAIRE; STOMACH BIOPSY;

EID: 0034971549     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655201300191978     Document Type: Article

References (56)

1. Bleeding peptic ulcer
2. Natural history of duodenal ulcer disease: Are we at a turning point?
3. Helicobacter pylori eradication: The best long-term prophylaxis for ulcer bleeding recurrence?
4. The prevalence of Helicobacter pylori in peptic ulcer disease
5. H. pylori-negative duodenal ulcer prevalence and causes in 774 patients
6. What is the role of Helicobacter pylori in complicated ulcer disease?
7. Helicobacter pylori and non-steroidal anti-inflammatory drugs. The Year in Helicobacter pylori
8. The measurement of observer agreement for categorical data
9. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer
10. The prevalence of Helicobacter pylori and NSAID use in patients with severe UGI hemorrhage and their potential role in recurrence of ulcer bleeding
11. Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly: A case-control study
12. Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding
13. Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: The prevalence of the infection, the efficacy of three triple therapies and the role of eradication in preventing a hemorrhagic recurrence
14. Infección por Helicobacter pylori en pacientes con hemorragia digestiva alta de origen péptico:comparación de métodos diagnósticos
15. Ulcer site and complications: Relation to Helicobacter pylori infection and NSAID use
16. Is the H. pylori negative bleeding duodenal ulcer a myth?
17. Low sensitivity of invasive tests for the detection of Helicobacter pylori infection in patients with bleeding ulcer
18. Rapid urease test is less sensitive than histology in diagnosing Helicobacter pylori infection in patients with non-variceal upper gastrointestinal bleeding
19. Prospective study on the influence of gastroduodenal ulcer hemorrhage on the diagnostic methods in Helicobacter pylori infection
20. Comparison of invasive and noninvasive tests for detecting Helicobacter pylori infection in bleeding peptic ulcers
21. Confounding factors in the detection of Helicobacter pylori infection in patients with upper gastrointestinal bleeding
22. False-negative biopsy urease test in bleeding ulcers caused by the buffering effects of blood
23. The effects of blood on rapid urease testing for Helicobacter pylori in mucosal biopsies from the gastric antrum
24. Bleeding ulcers have high false negative rates for antral Helicobacter pylori when tested with urease test
25. High rates of false negative rapid urease test (CLO) in patients with upper gastrointestinal bleeding (UGB)
26. Diagnostic tests for Helicobacter pylori: Comparison and influence of non-steroidal anti-inflammatory drugs
27. Serological diagnosis of Helicobacter pylori - Evaluation of four tests in the presence or absence of non-steroidal anti-inflammatory drugs
28. Does blood in the stomach influence the diagnosis of H. pylori infection in patients with bleeding peptic ulcer?
29. Diagnosis of Helicobacter pylori infection in acute upper gastrointestinal haemorrhage; what is the best diagnostic test?
30. Guidelines for clinical trials in Helicobacter pylori infection
31. The conflicting relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding
32. Urea breath tests in the management of Helicobacter pylori infection
33. Helicobacter pylori increases the risk of peptic ulcer bleeding: A case-control study
34. Peptic ulcer bleeding: Interaction between non-steroidal anti-inflammatory drugs, Helicobacter pylori infection, and the ABO blood group system
35. Peptic ulcer bleeding in the elderly: Relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs
36. Helicobacter pylori and the relation to other risk factors in patients with acute bleeding peptic ulcer
37. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: A case-control study
38. Non-steroidal anti-inflammatory drugs, Helicobacter pylori and bleeding gastric ulcer
39. Risk of ulcer bleeding in patients infected with Helicobacter pylori taking non-steroidal anti-inflammatory drugs
40. Interaction between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding
41. Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users
42. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage
43. One-week antibiotics versus maintenance acid suppression therapy for Helicobacter pylori-associated peptic ulcer bleeding
44. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease
45. Ulcer risk factors: Interactions between Helicobacter pylori infection, nonsteroidal use, and age
46. Helicobacter pylori-negative gastric ulcer
47. Peptic ulcer haemorrhage in Tartu County, Estonia: Epidemiology and mortality risk factors
48. Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori
49. Helicobacter pylori infection. The Spanish consensus report
50. Predictors of duodenal ulcer healing and relapse
51. Should H. pylori infection in duodenal ulcer be confirmed before administering eradicating treatment?
52. A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration
53. Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding
54. Campylobacter pylori and peptic ulcer disease
55. Helicobacter pylori and bleeding peptic ulcer: Do we really need a gold standard?
56. Intravenous omeprazole/amoxicillin and omeprazole pretreatment in Helicobacter pylori-positive acute peptide ulcer bleeding